In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Jasper Therapeutics (JSPR – Research Report), with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback